112 related articles for article (PubMed ID: 28397445)
1. "From right to left": The role of right heart catheterization in the diagnosis and management of left heart diseases.
Kałużna-Oleksy M; Araszkiewicz A; Migaj J; Lesiak M; Straburzyńska-Migaj E
Adv Clin Exp Med; 2017; 26(1):135-141. PubMed ID: 28397445
[TBL] [Abstract][Full Text] [Related]
2. Updated Hemodynamic Definition and Classification of Pulmonary Hypertension.
Lechartier B; Kularatne M; Jaïs X; Humbert M; Montani D
Semin Respir Crit Care Med; 2023 Dec; 44(6):721-727. PubMed ID: 37595614
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary hypertension associated with left heart disease (group 2)].
Wissmüller M; Tichelbäcker T; Finke K; Dohr J; Adler J; Ochs L; Hohmann C; Baldus S; Rosenkranz S
Dtsch Med Wochenschr; 2023 Nov; 148(23):1498-1506. PubMed ID: 37949078
[TBL] [Abstract][Full Text] [Related]
4. The Diagnostic Approach to Pulmonary Hypertension.
Torbicki A; Kurzyna M
Semin Respir Crit Care Med; 2023 Dec; 44(6):728-737. PubMed ID: 37487526
[TBL] [Abstract][Full Text] [Related]
5. What changed after the 2022 guidelines for pulmonary hypertension?
Lichtblau M; Titz A; Bahrampoori B; Schmiedeskamp M; Ulrich S
Eur J Intern Med; 2023 Dec; 118():1-5. PubMed ID: 37673774
[TBL] [Abstract][Full Text] [Related]
6. Right heart catheterization in idiopathic pulmonary hypertension: An all-inclusive necessity.
Adhyapak SM; Konda A; K T T; Shivakumar ; Varghese K
Curr Probl Cardiol; 2024 Aug; 49(8):102642. PubMed ID: 38750992
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the 2022 European Society of Cardiology/European Respiratory Society Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.
Mohananey D; Martin AK; Mandawat H; Hauser JM; Ramakrishna H
J Cardiothorac Vasc Anesth; 2024 Feb; 38(2):534-541. PubMed ID: 38052693
[No Abstract] [Full Text] [Related]
8. Clinical update on pulmonary hypertension.
Yaghi S; Novikov A; Trandafirescu T
J Investig Med; 2020 Apr; 68(4):821-827. PubMed ID: 32241822
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the Pan African Pulmonary hypertension Cohort (PAPUCO) study: implementing a contemporary registry on pulmonary hypertension in Africa.
Thienemann F; Dzudie A; Mocumbi AO; Blauwet L; Sani MU; Karaye KM; Ogah OS; Mbanze I; Mbakwem A; Udo P; Tibazarwa K; Ibrahim AS; Burton R; Damasceno A; Stewart S; Sliwa K
BMJ Open; 2014 Oct; 4(10):e005950. PubMed ID: 25763797
[TBL] [Abstract][Full Text] [Related]
10. [New aspects in pediatric pulmonary hypertension - Commented 2022ERS/ESC-PH guidelines].
Apitz C; Kozlik-Feldmann R; Eichstaedt CA; Gorenflo M; Lammers AE; Geiger R
Pneumologie; 2023 Nov; 77(11):947-955. PubMed ID: 37963484
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension.
Newman JH
Am J Respir Crit Care Med; 2005 Nov; 172(9):1072-7. PubMed ID: 15994464
[TBL] [Abstract][Full Text] [Related]
12. New guidelines for managing pulmonary hypertension: what the pediatrician needs to know.
Abman SH
Curr Opin Pediatr; 2016 Oct; 28(5):597-606. PubMed ID: 27583409
[TBL] [Abstract][Full Text] [Related]
13. Right heart catheterization for pulmonary hypertension during the coronavirus disease 2019 pandemic.
Qaiser KN; Lane JE; Tonelli AR
Pulm Circ; 2020; 10(3):2045894020948783. PubMed ID: 32983409
[TBL] [Abstract][Full Text] [Related]
14. [2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].
Humbert M; Kovacs G; Hoeper MM; Badagliacca R; Berger RMF; Brida M; Carlsen J; Coats AJS; Escribano-Subias P; Ferrari P; Ferreira DS; Ghofrani HA; Giannakoulas G; Kiely DG; Mayer E; Meszaros G; Nagavci B; Olsson KM; Pepke-Zaba J; Quint JK; Rådegran G; Simonneau G; Sitbon O; Tonia T; Toshner M; Vachiery JL; Vonk Noordegraaf A; Delcroix M; Rosenkranz S;
G Ital Cardiol (Rome); 2023 Apr; 24(4 Suppl 1):e1-e116. PubMed ID: 36995376
[No Abstract] [Full Text] [Related]
15. Nitric oxide: A possible new biomarker in heart failure? Relationship with pulmonary hypertension secondary to left heart failure.
Lahera V
Clin Investig Arterioscler; 2017; 29(3):127-128. PubMed ID: 28499461
[No Abstract] [Full Text] [Related]
16. RV Contractile Function and its Coupling to Pulmonary Circulation in Heart Failure With Preserved Ejection Fraction: Stratification of Clinical Phenotypes and Outcomes.
Guazzi M; Dixon D; Labate V; Beussink-Nelson L; Bandera F; Cuttica MJ; Shah SJ
JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt B):1211-1221. PubMed ID: 28412423
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase-5 Inhibitors Improve Clinical Outcomes, Exercise Capacity and Pulmonary Hemodynamics in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis.
De Vecchis R; Cesaro A; Ariano C; Giasi A; Cioppa C
J Clin Med Res; 2017 Jun; 9(6):488-498. PubMed ID: 28496549
[TBL] [Abstract][Full Text] [Related]
18. Invasive Hemodynamic Assessment of Patients with Heart Failure and Pulmonary Hypertension.
Patil RK; Goyal P; Swaminathan RV; Kim LK; Feldman DN
Curr Treat Options Cardiovasc Med; 2017 Jun; 19(6):40. PubMed ID: 28466117
[TBL] [Abstract][Full Text] [Related]
19. From systemic and pulmonary hypertension to heart failure: novel drugs and devices.
Lüscher TF
Eur Heart J; 2017 Apr; 38(15):1087-1090. PubMed ID: 28419291
[No Abstract] [Full Text] [Related]
20. Impaired Right Heart and Pulmonary Vascular Function in HFpEF: Time for More Risk Markers?
Kaye DM; Marwick TH
JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt B):1222-1224. PubMed ID: 28412416
[No Abstract] [Full Text] [Related]
[Next] [New Search]
